NO20072237L - Et bakterielt ATP-syntasebindingsdomene - Google Patents

Et bakterielt ATP-syntasebindingsdomene

Info

Publication number
NO20072237L
NO20072237L NO20072237A NO20072237A NO20072237L NO 20072237 L NO20072237 L NO 20072237L NO 20072237 A NO20072237 A NO 20072237A NO 20072237 A NO20072237 A NO 20072237A NO 20072237 L NO20072237 L NO 20072237L
Authority
NO
Norway
Prior art keywords
binding domain
atp synthase
atpe protein
pharmaceutical compositions
bacterial atp
Prior art date
Application number
NO20072237A
Other languages
English (en)
Other versions
NO342699B1 (no
Inventor
Koenraad Jozef Lodewij Andries
Hinrich Wilhelm Helmu Gohlmann
Jean-Marc Edmond Fernand Neefs
Peter Karel Maria Verhasselt
Johann Winkler
Marc Rene De Jonge
Lucien Maria Henricus Koymans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20072237L publication Critical patent/NO20072237L/no
Publication of NO342699B1 publication Critical patent/NO342699B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)

Abstract

Denne oppfinnelse tilveiebringer et isolert mutant atpE-protein og avvikende fra nevnte mutante atpE-protein identifikasjonen av et ATPase-bindingsdomene. Denne oppfinnelse tilveiebringer også beslektede nukleinsyrer, vektorer, vertsceller, farmasøytiske sammensetninger og produksjonsprodukter. Denne oppfinnelse tilveiebringer videre metoder for å bestemme hvorvidt en testforbindelse samhandler med et atpE-protein, dvs. med ATPase-bindingsdomenet ifølge foreliggende oppfinnelse, samt farmasøytiske sammensetninger omfattende nevnte testforbindelse, spesielt som antimikrobiske midler, mer spesielt som antimykobakterielle midler, enda mer spesielt for å behandle tuberkulose i et individ.
NO20072237A 2004-09-28 2007-04-30 Et bakterielt ATP-syntasebindingsdomene. NO342699B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04104720 2004-09-28
US62050004P 2004-10-20 2004-10-20
PCT/EP2005/054893 WO2006035051A1 (en) 2004-09-28 2005-09-28 A bacterial atp synthase binding domain

Publications (2)

Publication Number Publication Date
NO20072237L true NO20072237L (no) 2007-06-25
NO342699B1 NO342699B1 (no) 2018-07-09

Family

ID=38965678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072237A NO342699B1 (no) 2004-09-28 2007-04-30 Et bakterielt ATP-syntasebindingsdomene.

Country Status (24)

Country Link
US (2) US8088891B2 (no)
EP (1) EP1797115B1 (no)
JP (2) JP2008515395A (no)
KR (1) KR101539021B1 (no)
CN (1) CN101065397B (no)
AU (2) AU2005288848A1 (no)
CA (1) CA2579971C (no)
CY (1) CY1119568T1 (no)
DK (1) DK1797115T3 (no)
ES (1) ES2636980T3 (no)
HR (1) HRP20171388T1 (no)
HU (1) HUE033609T2 (no)
IL (1) IL182185A (no)
LT (1) LT1797115T (no)
ME (1) ME02935B (no)
NO (1) NO342699B1 (no)
NZ (1) NZ553693A (no)
PL (1) PL1797115T3 (no)
PT (1) PT1797115T (no)
RS (1) RS56357B1 (no)
RU (1) RU2418001C2 (no)
SI (1) SI1797115T1 (no)
WO (1) WO2006035051A1 (no)
ZA (1) ZA200702540B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2440736A (en) * 2006-08-10 2008-02-13 Medical Res Council Crystals of mutant p53 polypeptidtes
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
KR102110355B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
CA2869453C (en) 2012-04-27 2021-03-02 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US8454434B1 (en) * 2012-06-15 2013-06-04 Igt Gaming system and method for providing an offer and acceptance game with progressive awards associated with a quantity of progressive tokens
JP5580383B2 (ja) 2012-10-05 2014-08-27 株式会社 資生堂 美容機器及び通電方法及び記録媒体
KR101522087B1 (ko) * 2013-06-19 2015-05-28 삼성에스디에스 주식회사 미스매치를 고려한 염기 서열 정렬 시스템 및 방법
CN110373399B (zh) * 2019-07-09 2021-05-28 湖南省植物保护研究所 一种沼泽红假单胞菌Atps2蛋白及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US6583266B1 (en) * 1993-08-19 2003-06-24 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics
RU2245719C2 (ru) * 2000-03-28 2005-02-10 Каунсил Оф Сайентифик Энд Индастриал Рисерч Тимолсодержащая композиция, полезная для лечения устойчивых к лекарственным средствам бактериальных инфекций
US20040096894A1 (en) * 2000-05-19 2004-05-20 Somers William Stuart Crystal structures of P- selectin, P- and E-selectin complexes, and uses thereof
EP1360286A2 (en) * 2000-09-19 2003-11-12 Chiron Corporation Characterization of the gsk-3beta protein and methods of use thereof
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
NZ532463A (en) 2001-11-13 2007-02-23 Dimensional Pharm Inc Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
DK1527050T3 (da) * 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
AU2002951853A0 (en) * 2002-10-04 2002-10-24 Commonwealth Scientific And Industrial Research Organisation Crystal structure of erbb2 and uses thereof

Also Published As

Publication number Publication date
DK1797115T3 (en) 2017-10-02
US8378085B2 (en) 2013-02-19
ME02935B (me) 2018-04-20
AU2012216368A1 (en) 2012-09-13
NO342699B1 (no) 2018-07-09
IL182185A0 (en) 2007-07-24
PT1797115T (pt) 2017-08-29
RU2007116144A (ru) 2008-11-10
ZA200702540B (en) 2008-08-27
ES2636980T3 (es) 2017-10-10
EP1797115A1 (en) 2007-06-20
CY1119568T1 (el) 2018-03-07
RS56357B1 (sr) 2017-12-29
KR20070073823A (ko) 2007-07-10
LT1797115T (lt) 2017-10-10
US8088891B2 (en) 2012-01-03
CN101065397A (zh) 2007-10-31
IL182185A (en) 2017-12-31
HUE033609T2 (en) 2017-12-28
WO2006035051A1 (en) 2006-04-06
RU2418001C2 (ru) 2011-05-10
AU2012216368B2 (en) 2017-04-13
HK1114619A1 (zh) 2008-11-07
CN101065397B (zh) 2015-10-21
CA2579971A1 (en) 2006-04-06
HRP20171388T1 (hr) 2017-11-03
PL1797115T3 (pl) 2017-12-29
JP2008515395A (ja) 2008-05-15
EP1797115B1 (en) 2017-06-21
JP5837852B2 (ja) 2015-12-24
NZ553693A (en) 2012-05-25
US20120219964A1 (en) 2012-08-30
SI1797115T1 (sl) 2017-10-30
CA2579971C (en) 2018-02-13
KR101539021B1 (ko) 2015-07-23
US20090298874A1 (en) 2009-12-03
JP2012210210A (ja) 2012-11-01
AU2005288848A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
NO20072237L (no) Et bakterielt ATP-syntasebindingsdomene
EP1994142A4 (en) METHOD AND COMPOSITIONS FOR FAST ISOLATION OF SMALL RNA MOLECULES
NO20092651L (no) Dihydropyridinderivater som er anvendelige som proteinkinaseinhibitorer
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
UA98101C2 (ru) Пептидные ингибиторы пути трансдукции сигнала jnk, которые имеют способность проникать в клетку
MX2009007548A (es) Derivados de glicina n-sustituidos: inhibidores de hidroxilasa.
NO20081013L (no) 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav
NO20071242L (no) Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer
MY149861A (en) Prolyl hydroxylase inhibitors
Shalev‐Malul et al. An AbrB‐like protein might be involved in the regulation of cylindrospermopsin production by Aphanizomenon ovalisporum
WO2006044728A3 (en) Methods for isolation of nucleic acids from prokaryotic spores
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
CY1116482T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια ογκων, ινωσης, και πνευμονικης κυψελιδικης πρωτεϊνωσης
MX2007004841A (es) Triazoles utiles como inhibidores de proteinas cinasas.
Konovalova et al. A RelA‐dependent two‐tiered regulated proteolysis cascade controls synthesis of a contact‐dependent intercellular signal in Myxococcus xanthus
WO2008054514A8 (en) Differential expression profiling analysis of cell culture phenotypes and the uses thereof
Franke et al. Plasticity of the malleobactin pathway and its impact on siderophore action in human pathogenic bacteria
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
WO2008021367A3 (en) Moenomycin biosynthesis-related compositions and methods of use thereof
WO2006138606A3 (en) Cell signaling genes and related methods
NO20060360L (no) Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer
MY192948A (en) Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
Liggins et al. Comparison of sporulation and germination conditions for Clostridium perfringens type A and G strains
ATE487721T1 (de) Triaza-benzoäeüazulenderivate zur behandlung von tumoren
Mukherjee et al. The C-terminal domain of HU-related histone-like protein Hlp from Mycobacterium smegmatis mediates DNA end-joining